Bag-In/Bag-Out (BIBO) filter housing systems represent a critical containment technology designed to protect personnel, environments, and processes from exposure to hazardous airborne contaminants during filter maintenance and replacement operations. These systems are engineered to maintain absolute containment integrity when handling high-efficiency particulate air (HEPA) and ultra-low penetration air (ULPA) filters in high-risk environments, including biosafety level 3 and 4 laboratories (BSL-3/BSL-4), pharmaceutical manufacturing facilities, nuclear power installations, and other applications involving highly infectious microorganisms, toxic substances, or radioactive materials.
The fundamental design principle of BIBO systems addresses a critical vulnerability in conventional filtration systems: the potential for contamination release during filter changeout procedures. According to CDC guidelines for biosafety in microbiological and biomedical laboratories, proper containment during maintenance operations is essential to prevent occupational exposure and environmental contamination. BIBO technology provides a validated method for achieving this containment through a sealed, double-bagging isolation protocol.
BIBO filter housings employ a hermetically sealed enclosure design that isolates contaminated filters from the surrounding environment throughout their entire service life, including installation, operation, and removal. The core engineering principles include:
Primary Containment Barrier: The filter housing itself serves as the primary containment boundary, constructed from corrosion-resistant materials (typically 304 or 316 stainless steel) with full-penetration welded seams to ensure gas-tight integrity. This construction method eliminates potential leak paths that could exist in bolted or gasketed assemblies.
Double-Bag Isolation Protocol: The defining characteristic of BIBO systems is the double-bagging mechanism that maintains continuous containment during filter replacement:
This dual-barrier approach ensures that contaminated filter media never comes into direct contact with personnel or the surrounding environment, meeting the stringent requirements of ISO 14644-7 (Separative devices - Clean air hoods, gloveboxes, isolators and mini-environments) and WHO Laboratory Biosafety Manual guidelines.
The hermetic sealing of BIBO housings is achieved through several engineering features:
| Design Feature | Technical Specification | Purpose |
|---|---|---|
| Welded Construction | Full-penetration TIG or MIG welds on all seams | Eliminates gasket leak paths |
| Material Thickness | Typically 1.5-3.0 mm stainless steel | Provides structural rigidity and torsional strength |
| Pressure Rating | ±2500 Pa to ±5000 Pa typical | Withstands system pressure fluctuations |
| Leak Rate | ≤0.01% at test pressure per ISO 14644-3 | Ensures containment integrity |
| Surface Finish | Ra ≤0.8 μm (electropolished options available) | Facilitates decontamination |
The gas-tight design is validated through pressure decay testing per ASME AG-1 (Code on Nuclear Air and Gas Treatment) or equivalent standards, ensuring that the housing maintains containment even under abnormal operating conditions.
Modern BIBO housings incorporate in-situ filter integrity testing capabilities to verify HEPA/ULPA filter performance without compromising containment. These systems typically include:
Aerosol Challenge Ports: Sealed injection points upstream of the filter allow introduction of test aerosols (typically PAO - polyalphaolefin, or DOP - dioctyl phthalate) for leak testing per ISO 14644-3 and IEST-RP-CC034 (HEPA and ULPA Filter Leak Tests).
Downstream Sampling Ports: Multiple sampling locations downstream of the filter enable photometric scanning to detect filter media defects, gasket leaks, or frame seal failures. The scanning resolution typically allows detection of leaks as small as 0.01% of the challenge aerosol concentration.
Continuous Monitoring Options: Some installations incorporate permanent photometers or particle counters for real-time filter integrity monitoring, providing early warning of filter degradation or breakthrough.
| Test Method | Standard Reference | Detection Limit | Application |
|---|---|---|---|
| PAO Photometric Scan | ISO 14644-3, IEST-RP-CC034 | 0.01% penetration | BSL-3/4, pharmaceutical |
| DOP Photometric Scan | FDA Aseptic Processing Guidance | 0.01% penetration | Sterile manufacturing |
| Particle Counter Scan | ISO 14644-1, EU GMP Annex 1 | Individual particles ≥0.3 μm | Cleanroom validation |
| Pressure Differential | ASHRAE 52.2, EN 779 | ±5 Pa accuracy | Routine monitoring |
BIBO housings designed for high-containment applications incorporate sealed ports for in-situ decontamination prior to filter replacement. This capability is essential for BSL-3/4 laboratories and pharmaceutical isolator systems where filters may be contaminated with viable pathogens or potent active pharmaceutical ingredients (APIs).
Decontamination Methods and Ports:
| Method | Agent | Typical Concentration | Contact Time | Standard Reference |
|---|---|---|---|---|
| Vaporized Hydrogen Peroxide (VHP) | H₂O₂ vapor | 300-1400 ppm | 30-180 minutes | ISO 14937, FDA Guidance |
| Formaldehyde Gas | HCHO | 5-10% solution vaporized | 6-12 hours | WHO Biosafety Manual |
| Chlorine Dioxide | ClO₂ gas | 0.5-5 mg/L | 30-120 minutes | EPA Guidance |
| Peracetic Acid Vapor | CH₃CO₃H | 0.2-2% vaporized | 30-60 minutes | ISO 14937 |
Decontamination ports are designed with double-valve isolation to prevent contamination release during connection and disconnection of decontamination equipment. The housing interior surface finish (typically electropolished to Ra ≤0.8 μm) facilitates complete decontamination by minimizing surface irregularities where contaminants could harbor.
BIBO housings are designed to accommodate high-efficiency filters meeting international standards for particulate removal:
| Filter Class | Standard | Minimum Efficiency | Typical Application |
|---|---|---|---|
| H13 (HEPA) | ISO 29463, EN 1822 | ≥99.95% at MPPS* | BSL-2, pharmaceutical Grade C/D |
| H14 (HEPA) | ISO 29463, EN 1822 | ≥99.995% at MPPS | BSL-3, pharmaceutical Grade B |
| U15 (ULPA) | ISO 29463, EN 1822 | ≥99.9995% at MPPS | BSL-4, semiconductor |
| U16 (ULPA) | ISO 29463, EN 1822 | ≥99.99995% at MPPS | Nuclear, high-containment research |
| U17 (ULPA) | ISO 29463, EN 1822 | ≥99.999995% at MPPS | Specialized nuclear applications |
*MPPS = Most Penetrating Particle Size (typically 0.1-0.3 μm)
The H14 filter classification, commonly specified for BSL-3 and pharmaceutical applications, provides a minimum efficiency of 99.995% at the most penetrating particle size, effectively capturing bacteria (typically 0.5-5 μm), viruses (0.02-0.3 μm), and fungal spores (2-10 μm).
BIBO housing design must balance containment integrity with acceptable airflow resistance:
| Parameter | Typical Range | Design Consideration |
|---|---|---|
| Face Velocity | 0.3-0.5 m/s (supply), 0.4-0.6 m/s (exhaust) | Per ISO 14644-4 and ASHRAE 52.2 |
| Initial Pressure Drop (H14) | 200-350 Pa at rated flow | Depends on filter media and pleating |
| Final Pressure Drop (replacement) | 500-750 Pa typical | Per manufacturer specifications |
| Housing Pressure Drop | 20-50 Pa | Minimized through aerodynamic design |
| System Pressure Rating | ±2500 Pa to ±5000 Pa | Structural design requirement |
The pressure drop across the filter increases over time as particulate matter accumulates on the media surface. Differential pressure monitoring is essential for determining filter replacement intervals, typically specified when pressure drop reaches 2-3 times the initial clean filter value or when filter integrity testing indicates degradation.
| Component | Material Specification | Standard Reference | Rationale |
|---|---|---|---|
| Housing Body | 304/316/316L stainless steel | ASTM A240, ASME BPE | Corrosion resistance, cleanability |
| Welds | Full-penetration TIG/MIG | ASME Section IX, AWS D1.6 | Hermetic sealing, structural integrity |
| Gaskets (filter seal) | Silicone, EPDM, or neoprene | ASTM D2000 | Chemical compatibility, temperature range |
| Bag Material | Polyethylene or PVC (6-mil minimum) | ASTM D6400 | Puncture resistance, flexibility |
| Fasteners | 316 stainless steel | ASTM F593, F594 | Corrosion resistance |
| Surface Finish | Ra ≤0.8 μm (electropolished) | ASME BPE SF-4 | Decontamination efficacy |
BIBO housings are available in standardized sizes corresponding to common filter dimensions:
| Filter Size (mm) | Housing Dimensions (mm) | Typical Airflow (m³/h) | Weight (kg) |
|---|---|---|---|
| 305 × 305 × 150 | 400 × 400 × 300 | 850-1200 | 25-35 |
| 610 × 610 × 150 | 700 × 700 × 300 | 3400-4800 | 60-80 |
| 610 × 610 × 292 | 700 × 700 × 450 | 5100-7200 | 80-110 |
| 915 × 610 × 292 | 1000 × 700 × 450 | 7650-10800 | 110-150 |
Installation considerations include:
BIBO filter housings must comply with multiple overlapping standards depending on application:
| Standard | Issuing Body | Scope | Key Requirements for BIBO |
|---|---|---|---|
| ISO 14644-3 | ISO | Test methods for cleanrooms | Filter leak testing protocols, acceptance criteria |
| ISO 14644-4 | ISO | Design and construction | Containment device specifications |
| ISO 14644-7 | ISO | Separative devices | Isolator and containment system design |
| ISO 29463 | ISO | Filter classification | HEPA/ULPA efficiency testing and rating |
| EN 1822 | CEN | High efficiency filters | European filter testing and classification |
| IEST-RP-CC001 | IEST | HEPA/ULPA filters | Filter construction and testing |
| IEST-RP-CC034 | IEST | Filter leak testing | In-situ testing procedures |
| ASME AG-1 | ASME | Nuclear air treatment | Design, materials, testing for nuclear applications |
| ASME N509 | ASME | Nuclear power plants | Air cleaning system requirements |
| ASME N510 | ASME | Nuclear facilities | In-service testing of air cleaning systems |
| Regulation/Guideline | Authority | Application | BIBO-Relevant Requirements |
|---|---|---|---|
| WHO Laboratory Biosafety Manual (4th Ed.) | WHO | BSL-1 through BSL-4 | Containment during maintenance, decontamination protocols |
| CDC/NIH BMBL (6th Ed.) | CDC/NIH | Biosafety in US laboratories | Primary containment devices, filter handling procedures |
| EU GMP Annex 1 (2022) | EMA | Sterile pharmaceutical manufacturing | Contamination control, filter integrity testing |
| FDA Aseptic Processing Guidance | FDA | US pharmaceutical manufacturing | HEPA filter validation, integrity testing frequency |
| 21 CFR Part 211 | FDA | Current Good Manufacturing Practice | Equipment design, maintenance, validation |
| USP <797> | USP | Compounding sterile preparations | Environmental control, filter testing |
| USP <800> | USP | Hazardous drug handling | Containment during maintenance |
For nuclear facilities and radioactive material handling, additional standards apply:
| Standard | Focus | BIBO Requirements |
|---|---|---|
| 10 CFR Part 20 | Radiation protection | Containment of radioactive particulates |
| 10 CFR Part 50 Appendix A | Nuclear power plant design | Safety-related air cleaning systems |
| ASME AG-1 Section FC | Filter housings | Structural design, leak-tightness testing |
| ASME N509 | Air cleaning systems | Housing design, testing, quality assurance |
| ASME N510 | In-service testing | Periodic leak testing, pressure drop monitoring |
| DOE-STD-3020 | DOE facilities | Confinement ventilation systems |
BSL-3 and BSL-4 laboratories handle highly infectious agents that pose severe or potentially lethal risks through aerosol transmission. BIBO systems in these facilities must meet stringent containment requirements:
BSL-3 Applications:
- Mycobacterium tuberculosis research
- SARS-CoV-2 and other respiratory pathogens
- Brucella, Coxiella burnetii, and other bacterial agents
- Arboviruses (West Nile, Rift Valley fever)
BSL-4 Applications:
- Ebola, Marburg, and other hemorrhagic fever viruses
- Nipah and Hendra viruses
- Variola (smallpox) virus in authorized facilities
- Novel pathogens with unknown transmission characteristics
| Requirement | BSL-3 | BSL-4 | Technical Implementation |
|---|---|---|---|
| Filter Efficiency | H14 minimum (≥99.995%) | U15 minimum (≥99.9995%) | Per ISO 29463 testing |
| Redundancy | Single-stage acceptable | Dual-stage required | Series filter arrangement |
| Leak Testing Frequency | Annually minimum | Semi-annually minimum | Per ASME N510 protocols |
| Decontamination | Required before maintenance | Required before and after maintenance | VHP or formaldehyde gas |
| Pressure Monitoring | Continuous with alarm | Continuous with alarm and interlock | ±10 Pa accuracy |
| Bag-Out Procedure | Double-bag protocol | Triple-bag protocol in some facilities | Per facility SOPs |
Pharmaceutical facilities use BIBO systems to maintain cleanroom classifications and prevent cross-contamination during filter maintenance:
Sterile Manufacturing (EU GMP Grade A/B, ISO Class 5):
- Aseptic filling operations
- Lyophilization processes
- Terminal sterilization areas
- Sterility testing isolators
High-Potency API Handling (OEL <10 μg/m³):
- Cytotoxic drug manufacturing
- Hormone production facilities
- Highly sensitizing compounds
- Controlled substance manufacturing
| Parameter | Sterile Products | High-Potency APIs | Rationale |
|---|---|---|---|
| Filter Class | H14 (≥99.995%) | H14 (≥99.995%) | Particle and microbial control |
| Integrity Testing | Every 6 months or after intervention | Annually or after intervention | EU GMP Annex 1, FDA guidance |
| Decontamination Agent | VHP, peracetic acid | VHP, chlorine dioxide | Sporicidal efficacy, material compatibility |
| Bag Material | Autoclavable or disposable | Chemical-resistant, disposable | Waste handling requirements |
| Documentation | Full validation package | Full validation package | 21 CFR Part 211, EU GMP |
| Change Control | Formal change control required | Formal change control required | Quality system requirements |
Nuclear facilities employ BIBO systems to prevent release of radioactive particulates during filter maintenance:
Applications:
- Nuclear power plant ventilation systems
- Hot cell exhaust filtration
- Glove box ventilation
- Radioactive waste processing facilities
- Medical isotope production
| Requirement | Specification | Standard Reference |
|---|---|---|
| Filter Efficiency | H14 or U15 depending on isotopes | ASME AG-1, 10 CFR Part 50 |
| Housing Construction | ASME Section III, Class 3 or better | ASME AG-1 Section FC |
| Seismic Qualification | Site-specific seismic design | ASCE 4, IEEE 344 |
| Radiation Resistance | Materials qualified for dose environment | ASTM D1672, ASTM D3681 |
| Leak Testing | 0.01% maximum penetration | ASME N510 |
| Testing Frequency | 18 months maximum | ASME N510, 10 CFR Part 50 |
| Quality Assurance | NQA-1 program required | 10 CFR Part 50 Appendix B |
Cleanroom environments for semiconductor fabrication require ULPA filtration to achieve ISO Class 1-3 conditions:
| Cleanroom Class | Particle Limit (≥0.1 μm/m³) | Filter Requirement | BIBO Application |
|---|---|---|---|
| ISO Class 1 | ≤10 | U16-U17 (≥99.99995%) | Critical process tools |
| ISO Class 2 | ≤100 | U15-U16 (≥99.9995%) | Lithography areas |
| ISO Class 3 | ≤1,000 | U15 (≥99.9995%) | General fabrication |
| ISO Class 4 | ≤10,000 | H14 (≥99.995%) | Support areas |
Proper BIBO system selection begins with comprehensive hazard assessment:
Biological Hazards:
1. Risk Group Classification (WHO/CDC): Risk Group 1 (low risk) through Risk Group 4 (high risk)
2. Transmission Route: Aerosol, droplet, contact, vector-borne
3. Infectious Dose: ID₅₀ or ID₉₅ values where known
4. Environmental Stability: Survival time on surfaces and in aerosols
5. Treatment Availability: Prophylaxis, vaccines, therapeutic options
Chemical Hazards:
1. Occupational Exposure Limit (OEL): Categorization from >1000 μg/m³ (low potency) to <0.1 μg/m³ (extremely high potency)
2. Toxicity Profile: Acute vs. chronic effects, target organs
3. Volatility: Vapor pressure and potential for vapor-phase contamination
4. Reactivity: Compatibility with decontamination agents and housing materials
Radiological Hazards:
1. Isotope Characteristics: Half-life, decay mode, energy
2. Annual Limit on Intake (ALI): Per 10 CFR Part 20
3. Derived Air Concentration (DAC): Airborne concentration limits
4. Contamination Potential: Dispersibility and surface contamination risk
| Hazard Level | Minimum Filter Efficiency | Housing Features Required |
|---|---|---|---|
| Low (BSL-1, OEL >100 μg/m³) | H13 (≥99.95%) | Standard BIBO, single-stage |
| Moderate (BSL-2, OEL 10-100 μg/m³) | H14 (≥99.995%) | Standard BIBO, decontamination port |
| High (BSL-3, OEL 1-10 μg/m³) | H14 (≥99.995%) | Enhanced BIBO, integrated scanning, decontamination |
| Very High (BSL-4, OEL <1 μg/m³) | U15 (≥99.9995%) | Dual-stage BIBO, continuous monitoring, redundant seals |
| Extreme (Nuclear, specialized) | U16-U17 (≥99.99995%) | ASME AG-1 qualified, seismic rated, radiation resistant |
BIBO housing selection must account for system airflow requirements and pressure relationships:
Supply Air Applications:
- Positive pressure relative to surrounding spaces
- Typical face velocity: 0.3-0.5 m/s
- Pressure drop budget: 300-500 Pa including housing and filter
- Upstream pre-filtration: MERV 14-16 (ISO ePM1 70-90%) recommended
Exhaust Air Applications:
- Negative pressure relative to surrounding spaces
- Typical face velocity: 0.4-0.6 m/s
- Pressure drop budget: 400-600 Pa including housing and filter
- Downstream considerations: Ductwork to atmosphere or recirculation
| System Type | Pressure Relationship | BIBO Placement | Additional Considerations |
|---|---|---|---|
| BSL-3 Supply | +15 to +20 Pa vs. corridor | After final AHU stage | Pre-filter protection essential |
| BSL-3 Exhaust | -30 to -40 Pa vs. corridor | Before exhaust fan | Redundant filtration recommended |
| BSL-4 Supply | +40 to +60 Pa vs. suit area | After final AHU stage | Dual-stage filtration |
| BSL-4 Exhaust | -60 to -80 Pa vs. suit area | Dual-stage before fan | Continuous monitoring required |
| Pharmaceutical Isolator | -10 to -20 Pa vs. room | Supply and exhaust | Pressure cascade maintenance |
| Nuclear Hot Cell | -125 to -250 Pa vs. operating area | Multi-stage exhaust | Seismic and radiation qualified |
Selection of decontamination method impacts housing material and design requirements:
| Decontamination Agent | Material Compatibility | Cycle Time | Efficacy | Limitations |
|---|---|---|---|---|
| Vaporized H₂O₂ (VHP) | 316L SS, electropolished | 2-4 hours | 6-log bacterial spores | Requires humidity control, material compatibility |
| Formaldehyde Gas | 304/316 SS, standard finish | 8-24 hours | 6-log bacterial spores | Carcinogenic, requires neutralization, slow |
| Chlorine Dioxide | 316L SS, electropolished | 2-3 hours | 6-log bacterial spores | Corrosive to some metals, explosive at high concentration |
| Peracetic Acid Vapor | 316L SS, electropolished | 1-2 hours | 6-log bacterial spores | Corrosive, requires ventilation |
Material Selection for Decontamination:
- Standard Applications: 304 stainless steel with Ra ≤1.6 μm finish
- Frequent Decontamination: 316L stainless steel with electropolished Ra ≤0.8 μm finish
- Chlorine Dioxide Use: 316L stainless steel mandatory, electropolished
- Gasket Materials: Silicone or EPDM for VHP/formaldehyde; Viton for chlorine dioxide
| Factor | Consideration | Impact on Selection |
|---|---|---|
| Filter Replacement Frequency | 1-5 years typical depending on loading | Affects bag material durability requirements |
| Personnel Training | Complexity of bag-out procedure | Simpler designs reduce training burden and error risk |
| Waste Handling | Contaminated filter disposal requirements | Bag size and material must accommodate waste stream |
| Space Constraints | Clearance required for bag-out operations | Compact designs available for limited access areas |
| Maintenance Windows | Facility downtime tolerance | Quick-change designs minimize system offline time |
| Documentation Requirements | Validation and compliance burden | Integrated test ports reduce validation complexity |
While specific pricing is vendor-dependent, key cost drivers include:
Initial Capital Costs:
- Housing construction quality (welded vs. bolted, material grade)
- Integrated testing systems (manual ports vs. automated scanning)
- Decontamination integration (simple ports vs. automated systems)
- Instrumentation (pressure gauges vs. electronic transmitters with alarms)
- Seismic and environmental qualification testing
Operational Costs:
- Filter replacement frequency (driven by process loading and pressure drop)
- Decontamination consumables (VHP, formaldehyde, etc.)
- Labor for filter changeout (complexity and duration of procedure)
- Validation and testing (frequency and complexity of integrity testing)
- Waste disposal (contaminated filter and bag disposal costs)
Risk Mitigation Value:
- Personnel exposure prevention (occupational health costs avoided)
- Environmental release prevention (regulatory penalties avoided)
- Product contamination prevention (batch loss costs avoided)
- Regulatory compliance (inspection findings and shutdown costs avoided)
| Parameter | Monitoring Frequency | Acceptance Criteria | Action if Out of Specification |
|---|---|---|---|
| Differential Pressure | Continuous with alarm | Initial DP to 2-3× initial DP | Investigate loading or filter damage |
| Airflow Rate | Monthly or continuous | ±10% of design flow | Check fan performance, duct restrictions |
| Visual Inspection | Weekly | No visible damage, corrosion, or leaks | Repair or replace damaged components |
| Gasket Condition | During filter change | No compression set, cracking, or degradation | Replace gaskets |
| Bag Integrity | Before each use | No tears, punctures, or degradation | Replace bags |
| Decontamination Port Seals | Quarterly | No leakage, proper valve operation | Service or replace valves |
In-Situ Aerosol Challenge Testing (per ISO 14644-3 and IEST-RP-CC034):
Acceptance Criteria by Application:
| Application | Maximum Allowable Penetration | Test Frequency | Standard Reference |
|---|---|---|---|
| BSL-3 Laboratory | 0.01% at any point | Annually | CDC BMBL, ASME N510 |
| BSL-4 Laboratory | 0.01% at any point | Semi-annually | CDC BMBL, ASME N510 |
| Pharmaceutical Grade A/B | 0.01% at any point | Every 6 months | EU GMP Annex 1 |
| Pharmaceutical Grade C/D | 0.01% at any point | Annually | EU GMP Annex 1 |
| Nuclear Safety-Related | 0.01% at any point | 18 months maximum | ASME N510, 10 CFR Part 50 |
| Semiconductor Cleanroom | 0.01% at any point | Annually or after intervention | ISO 14644-3 |
Hermetic housing integrity is verified through pressure decay testing:
Test Procedure (per ASME AG-1):
1. Isolate housing from system with blank flanges
2. Pressurize housing to test pressure (typically 2000-2500 Pa)
3. Monitor pressure decay over 10-15 minute period
4. Calculate leak rate from pressure decay
Acceptance Criteria:
- Leak rate ≤0.01% of housing volume per minute at test pressure
- Typical test pressure: 2× maximum operating pressure or 2500 Pa minimum
Test Frequency:
- Initial installation: Before commissioning
- After maintenance: Following any housing penetration or modification
- Periodic: Every 5 years or per facility requirements
Decontamination efficacy must be validated using biological indicators (BIs):
| Decontamination Method | Biological Indicator | Target Log Reduction | Placement Locations |
|---|---|---|---|
| Vaporized H₂O₂ | Geobacillus stearothermophilus spores | 6-log (10⁶) | Filter face, housing interior, dead legs |
| Formaldehyde Gas | Bacillus atrophaeus spores | 6-log (10⁶) | Filter face, housing interior, dead legs |
| Chlorine Dioxide | Geobacillus stearothermophilus spores | 6-log (10⁶) | Filter face, housing interior, dead legs |
| Peracetic Acid Vapor | Geobacillus stearothermophilus spores | 6-log (10⁶) | Filter face, housing interior, dead legs |
Validation Protocol:
1. Place BIs at worst-case locations (identified through mapping studies)
2. Perform decontamination cycle per validated parameters
3. Retrieve BIs and incubate per manufacturer instructions
4. Verify no growth (negative BIs indicate successful decontamination)
5. Document results and maintain validation records
Revalidation Triggers:
- Change in decontamination agent or concentration
- Modification to housing geometry or internal components
- Change in cycle parameters (time, temperature, humidity)
- Annually for critical applications (BSL-4, high-potency APIs)
Pre-Replacement Activities:
1. Decontamination: Perform validated decontamination cycle if handling hazardous materials
2. Isolation: Close isolation dampers and verify zero airflow
3. Pressure Equalization: Equalize pressure across filter to prevent bag rupture
4. PPE Donning: Don appropriate personal protective equipment per risk assessment
5. Bag Preparation: Inspect bags for integrity, prepare bag-out kit
Bag-Out Procedure (Double-Bag Protocol):
1. Attach outer bag to housing bag-out port with secure seal
2. Open housing access door (filter remains contained in inner bag)
3. Disconnect filter from housing frame while maintaining bag seal
4. Withdraw filter into outer bag, maintaining continuous containment
5. Seal outer bag with heat sealer or cable ties (double seal recommended)
6. Remove bagged filter and place in waste container
7. Decontaminate exterior of bag if required
Bag-In Procedure (New Filter Installation):
1. Place new filter in clean bag with open end
2. Attach bag to housing bag-in port
3. Insert filter through bag into housing
4. Secure filter to housing frame (gasket seal)
5. Withdraw and seal bag, leaving filter installed
6. Close and secure housing access door
7. Remove isolation, restore airflow gradually
Post-Replacement Activities:
1